Figure 1. LIMK1 siRNA downregulates
LIMK1 protein and suppresses fibronectin deposition in human corneal
fibroblasts. A: western blot analysis. Corneal fibroblasts were
transfected as indicated for 72 h. Cells were lysed and protein levels
were analyzed using LIMK1 and GAPGH antibodies. B-E:
Immunofluorescence microscopy using fibronectin antibody and DAPI
staining in fibroblast cultures (B) untreated; (C)
treated with 100 nM scrambled control siRNA; (D) treated with 50
nM of LIMK1-targeted siRNA; or (E) treated with 100 nM
of LIMK1-targeted siRNA. F: Quantitative analysis of
fibronectin secreted to the culture media by western blotting. Samples
were untreated or treated with control or LIMK1-targeted siRNA
as indicated. Experiments were performed 3 times yielding similar
results. Error bars represent standard deviation. The asterisk
indicates a p<0.025 (n=3) compared to scrambled siRNA.
![](images/mv-v14-1951-f1.jpg)